Effects of S-8510, a novel benzodiazepine receptor partial inverse agonist, on basal forebrain lesioning-induced dysfunction in rats

By Abe K.   Takeyama C.   Yoshimura K.  

European Journal of Pharmacology, Vol. 347, Iss. 2, 1998-04 ,pp. : 145-152

Elsevier

Access to resources Recommend Favorite

Dual action of the benzodiazepine receptor inverse agonist RU34347 on responses to exogenously applied GABA in the rat cerebellar slice - no reason for anxiety

By Pringle A.K.   Gardner C.R.   Walker R.J.  

General Pharmacology, Vol. 33, Iss. 2, 1999-08 ,pp. : 187-193

Elsevier

Access to resources Recommend Favorite

Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A

By De Vry J.   Schreiber R.   Eckel G.   Jentzsch K.R.  

European Journal of Pharmacology, Vol. 483, Iss. 1, 2004-01 ,pp. : 55-63

Elsevier

Access to resources Recommend Favorite

Rotarod studies in the rat of the GABA A receptor agonist gaboxadol: lack of ethanol potentiation and benzodiazepine cross-tolerance

By Voss J.   Sanchez C.   Michelsen S.   Ebert B.  

European Journal of Pharmacology, Vol. 482, Iss. 1, 2003-12 ,pp. : 215-222

Elsevier

Access to resources Recommend Favorite

Treatment with an antisense oligodeoxynucleotide to the GABA A receptor 2 subunit increases convulsive threshold for -CCM, a benzodiazepine 'inverse agonist', in rats

By Tai-jun Z.   Rosenberg H.C.   Chiu T.H.  

European Journal of Pharmacology, Vol. 306, Iss. 1, 1996-06 ,pp. : 61-66

Elsevier

Access to resources Recommend Favorite